Mainz (dpa/lrs) - Microsoft-Gründer Bill Gates hat den Mainzer Impfstoffhersteller Biontech besucht. Er traf bei dem Besuch ...
We rate BioNTech SE a hold due to volatile performance, weak growth, and premium valuation amidst COVID-19 vaccine reliance.
The headline news in the new agreement is the formation of a joint AI Innovation Lab – split between InstaDeep’s headquarters in London in the UK and BioNTech’s site in Mainz Germany ...
Durften Biontech und Pfizer die mRNA-Technologie der US-Konkurrenz auf Dauer lizenzfrei nutzen? Moderna überzieht das Mainzer ...
Durften Biontech und Pfizer die mRNA-Technologie der US-Konkurrenz auf Dauer lizenzfrei nutzen? Moderna überzieht das Mainzer ...
BioNTech SE operates as immunotherapy company ... 2008 and is headquartered in Mainz, Germany.
More about BioNTech SE BioNTech SE is a biotechnology company based in Mainz, Germany, primarily known for its development of mRNA-based vaccines and immunotherapies. The company is a significant ...
Executing in oncology with investigational BNT327/PM8002 combinations and mRNA cancer immunotherapy candidates as pan-tumor treatment approachesBioNTech aims to develop BNT327/PM8002 as a next-generat ...
Hosted on MSN20d
Truist Securities Initiates Coverage of BioNTech SE - Depositary Receipt () (BNTX) with Buy RecommendationBioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. Fintel is one of ...
Microsoft-Gründer Bill Gates hat den Mainzer Impfstoffhersteller Biontech besucht. Er traf bei dem Besuch am vergangenen Montag unter anderem die beiden Biontech-Mitbegründer Ugur Sahin und ...
https://www.tipranks.com/news/the-fly/si-bone-price-target-raised-to-20-from-19-at-needham BioNTech SE ( (BNTX) ) has provided an update. BioNTech SE has settled a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback